Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

$BLDR, $CRL, $COST, $ILMN, $INNT

Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts outlook for Key issues for Wednesday, as follows:

Builders FirstSource Inc. (NASDAQ:BLDR) was maintained as Outperform but the price target was cut to 27 from 30 at Wedbush Securities.

Charles River Laboratories International Inc. (NYSE:CRL) was raised to Outperform from Sector Perform with a 131 price target at RBC Capital Markets.

Costco Wholesale Corp. (NASDAQ:COST) was reiterated as Outperform and the price target was raised to 225 from 205 at Raymond James.

Illumina Inc. (NASDAQ:ILMN) was reiterated as Overweight and the price target was raised to 327 from 272 at Piper Jaffray.

Innovative BioPharma Inc. (NASDAQ:INNT) was started with a Buy rating and assigned a $35 price target at HC Wainwright.

Stay tuned…

The following two tabs change content below.
HEFFX has become one of Asia’s leading financial services companies with interests in Publishing, Private Equity, Capital Markets, Mining, Retail, Transport and Agriculture that span every continent of the world. Our clearing partners have unprecedented experience in Equities, Options, Forex and Commodities brokering, banking, physical metals dealing, floor brokering and trading.